• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Hard to Treat Diseases Inc/FL

+ Add to Watchlist


0.0000 USD 0.0001 100.00%

As of 20:10:00 ET on 01/06/2015.

Snapshot for Hard to Treat Diseases Inc/FL (HTDS)

Open: 0.0000 Day's Range: 0.0000 - 0.0000 Volume: 1,335,000
Previous Close: 0.0001 52wk Range: 0.0001 - 0.0002 1-Yr Rtn: -

Stock Chart for HTDS

No chart data available.
  • HTDS:US 0.0000
  • 1D
  • 1M
  • 1Y
Interactive HTDS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HTDS

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 0.05
Shares Outstanding (M) 5,482.34
30 Day Average Volume 52,833
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HTDS

No data available

Company Profile & Key Executives for HTDS

Hard to Treat Diseases Incorporated holds the international marketing rights, except South Korea, to Tubercin, an immunostimulant. The Company's product is a nasal spray developed for combating cancer and rheumatoid arthritis, targeted to the holistic product market. Hard to Treat Diseases is also seeking to market its chemical process for the disposal and recycling of Styrofoam.

Terry YuanChief Executive OfficerTony BiancoCOO
Sanja PekovicChief Project ScientistMirjana StojiljkovicMedical Advisor
More Company Profile & Key Executives for HTDS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil